Back to search
Strabismus
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Strabismus trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Strabismus trials you may qualify forThis project proposes to conduct a prospective, multicenter registry study in rural China to evaluate, under real-world conditions, the implementation effective…
Dexmedetomidine is a selective a-2 adrenergic agonist that provides sedative and analgesic effects. Intranasal dexmedetomidine has a slower and gradual onset co…
Amblyopia and strabismus are characterized by a reduction in visual acuity, contrast sensitivity, grating acuity, vernier acuity, reading difficulties and binoc…
The present trial conducted to demonstrate the administration of sugammadex as reversal of neuromuscular blockade agent reduces the incidence of emergence agita…
Craniosynostosis are cranial deformations due to the premature closure of one or more cranial sutures. These deformations affect approximately one in 2.500 birt…
The purpose of this study is to identify genes associated with impaired development and function of the cranial nerves and brainstem, which may result in misali…
Amblyopia is a common childhood visual disorder that affects vision in one eye and can also impair depth perception (stereopsis). Standard treatment typically i…
Intermittent strabismus is a condition in which the eyes occasionally become misaligned, affecting binocular vision, depth perception, and quality of life. Stan…
The purpose of this study is to determine if inducing a moderate or greater neuromuscular block (TOF count 0-3) when performing a neuromuscular block in pediatr…